Learn About Medicare Cannabis Coverage Options

Understanding Medicare and Cannabis: Current Federal Status

Medicare is the federal health insurance program that serves people age 65 and older, regardless of income. It also covers some younger people with disabilities and people with end-stage renal disease. As of 2024, Medicare does not cover cannabis or cannabis-derived products at the federal level. This is a critical fact to understand because Medicare operates under federal law, and cannabis remains classified as a Schedule I controlled substance under the Controlled Substances Act.

The federal classification means that from Medicare's perspective, cannabis has no recognized medical use, even though many states have legalized it for medical purposes. This creates a significant gap between state laws and federal policy. Some people with Medicare coverage may live in states where medical cannabis is legal and may want to use it for conditions like chronic pain, nausea, or multiple sclerosis. However, their Medicare coverage will not pay for it under any circumstances.

It is important to note that this policy applies to all forms of cannabis, including whole plant cannabis, cannabis oils, and cannabis-derived products. The only exception is Epidiolex, a prescription medication derived from cannabis that contains cannabidiol (CBD). Epidiolex is FDA-approved and may be covered by Medicare Part D (prescription drug coverage) for certain seizure disorders. This distinction is crucial because it shows that Medicare may cover cannabis-derived medications if they meet specific FDA approval requirements, but not cannabis itself.

The landscape around cannabis and Medicare could potentially change. There is ongoing research, legislative activity, and evolving state policies that may influence federal decisions in the future. However, individuals with Medicare should base their current planning on the fact that cannabis is not covered.

Practical takeaway: If you have Medicare and are considering cannabis for medical purposes, understand that federal Medicare coverage does not include it. Check your state's laws about medical cannabis, but plan to pay out-of-pocket if you decide to pursue it.

How Medicare Part D Prescription Drug Coverage Works

Medicare Part D is the prescription drug coverage portion of Medicare. It is offered through private insurance companies approved by Medicare. Part D covers medications approved by the FDA, which means they have gone through rigorous testing and been determined to be safe and effective for specific medical conditions. Understanding how Part D works is important because it explains why cannabis is not covered and why Epidiolex is the only cannabis-related medication with potential coverage.

Part D coverage operates on formularies, which are lists of medications that each insurance plan agrees to cover. These formularies vary from plan to plan, and each private insurance company decides which drugs to include. When a medication is on a formulary, Medicare pays a portion of the cost (the exact amount depends on your plan and which "tier" the drug is on), and you pay the rest through copayments or coinsurance. Medications not on any formulary are not covered by that plan.

The process for a medication to become available for Part D coverage is lengthy. A pharmaceutical company must first conduct clinical trials to prove that a drug is safe and effective. They then submit this data to the FDA. The FDA reviews the evidence and decides whether to approve the medication. If approved, the medication becomes available for Medicare Part D plans to consider. Individual insurance companies then decide whether to add it to their formularies based on cost, effectiveness, and their specific coverage decisions.

Epidiolex is covered by some Part D plans because it is an FDA-approved medication containing cannabidiol. It is specifically approved for treating certain types of seizures. If your doctor prescribes Epidiolex for a covered condition, you should check with your Part D plan to see if it is on your formulary. If it is, you will pay your normal copayment. If it is not on your plan's formulary, you may have options to request an exception or switch to a different Part D plan during the annual enrollment period.

Practical takeaway: Review your Part D formulary during Medicare's annual enrollment period to see what medications are covered. If you are interested in Epidiolex or any other medication, ask your doctor if it is appropriate for your condition and confirm coverage with your plan before starting it.

State Medical Cannabis Laws vs. Medicare Coverage

As of 2024, 38 states plus Washington D.C. have legalized medical cannabis in some form. This means that in these states, patients can obtain a prescription or recommendation from a doctor and purchase cannabis from a licensed dispensary. However, this state-level legalization does not change Medicare's federal policy. Medicare will not pay for cannabis even if you live in a state where it is legal and even if a doctor has recommended it.

This creates a confusing situation for many Medicare beneficiaries. You might live in a state where medical cannabis is legal, have a doctor who supports your use of it, and still have no insurance coverage for it. The reason is that Medicare is a federal program governed by federal law, and federal law does not recognize cannabis as a medication.

Some people mistakenly believe that state insurance programs or state Medicaid programs (which serve lower-income individuals) cover medical cannabis. While some state Medicaid programs have explored coverage in limited circumstances, coverage is very rare and varies significantly by state. For Medicare beneficiaries specifically, there is no coverage regardless of state laws.

The states with the most established medical cannabis programs include California, Colorado, Florida, New York, and Oregon. In these states, you can legally access cannabis with a doctor's recommendation, but you will need to pay the full cost out-of-pocket if you have Medicare. Prices for medical cannabis vary widely by state and product type. Flower typically costs $200 to $400 per ounce, while concentrates and edibles may range from $15 to $60 per product depending on the state and dispensary.

Some people use Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) to help pay for cannabis in states where it is legal, though this is a gray area legally and requires consulting with a tax professional. Generally, federal law does not recognize cannabis as a qualified medical expense for these accounts, so using HSA or FSA funds for cannabis could result in tax penalties.

Practical takeaway: If you live in a state with legal medical cannabis and are interested in using it, you should plan to pay the full cost out-of-pocket. Talk with your doctor about whether it might help your condition and understand the costs involved before pursuing it.

Research and Emerging Developments in Cannabis Medicine

Medical research on cannabis is ongoing and expanding. The National Institutes of Health, academic medical centers, and private research organizations are conducting studies on cannabis and cannabinoids for various conditions. This research is important because it may eventually lead to changes in federal policy and insurance coverage.

Current research is examining cannabis for conditions including chronic pain, epilepsy, multiple sclerosis, nausea from chemotherapy, and anxiety. Some studies show promising results, while others are inconclusive. For example, research on CBD for seizure disorders led to the FDA approval of Epidiolex, which is now available through Medicare Part D in some cases. This demonstrates that research can lead to approved medications and coverage.

The FDA is gradually approving more cannabis-derived medications. In addition to Epidiolex, Marinol and Cesamet are FDA-approved medications that contain synthetic cannabinoids and are covered by Medicare Part D for specific indications like nausea from chemotherapy. These medications went through the full FDA approval process, which is why they have coverage even though cannabis itself does not.

Legislative efforts at the federal level are also evolving. Some lawmakers have introduced bills to change cannabis's Schedule I classification or to allow Medicare coverage of medical cannabis. The Marijuana Opportunity Reinvestment and Expungement (MORE) Act and the SAFE Banking Act are examples of proposed legislation that could affect cannabis policy. However, these bills have not yet passed, and major policy changes would require significant Congressional action.

For Medicare beneficiaries, it is worth staying informed about research developments and policy changes, but you should not assume that coverage will change in the near future. Current decisions about your medical care should be based on today's coverage rules, not on speculation about future changes.

Practical takeaway: Follow reputable medical sources like the National Institutes of Health or major medical journals if you want to learn about cannabis research. Discuss research findings with your doctor to see if they are relevant to your specific health situation, but understand that research findings do not automatically translate to insurance coverage.

Paying Out-of-Pocket for Medical Cannabis

If you decide